171 related articles for article (PubMed ID: 27365404)
21. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.
Gheita TA; Bassyouni IH; Bassyouni RH
J Clin Immunol; 2012 Dec; 32(6):1279-86. PubMed ID: 22833165
[TBL] [Abstract][Full Text] [Related]
22. TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.
Wang X; Saso H; Iwamoto T; Xia W; Gong Y; Pusztai L; Woodward WA; Reuben JM; Warner SL; Bearss DJ; Hortobagyi GN; Hung MC; Ueno NT
Cancer Res; 2013 Nov; 73(21):6516-25. PubMed ID: 24014597
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of AXL receptor tyrosine kinase in osteosarcoma cells leads to decreased proliferation and increased apoptosis.
Zhang Y; Tang YJ; Man Y; Pan F; Li ZH; Jia LS
Int J Immunopathol Pharmacol; 2013; 26(1):179-88. PubMed ID: 23527720
[TBL] [Abstract][Full Text] [Related]
24. TAM receptors and the regulation of erythropoiesis in mice.
Tang H; Chen S; Wang H; Wu H; Lu Q; Han D
Haematologica; 2009 Mar; 94(3):326-34. PubMed ID: 19211638
[TBL] [Abstract][Full Text] [Related]
25. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
26. Cilostazol inhibits uremic toxin-induced vascular smooth muscle cell dysfunction: role of Axl signaling.
Lee CH; Hung YJ; Shieh YS; Chien CY; Hsu YJ; Lin CY; Chiang CF; Huang CL; Hsieh CH
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F398-F406. PubMed ID: 27927649
[TBL] [Abstract][Full Text] [Related]
27. Increased arterial blood pressure and vascular remodeling in mice lacking salt-inducible kinase 1 (SIK1).
Bertorello AM; Pires N; Igreja B; Pinho MJ; Vorkapic E; Wågsäter D; Wikström J; Behrendt M; Hamsten A; Eriksson P; Soares-da-Silva P; Brion L
Circ Res; 2015 Feb; 116(4):642-52. PubMed ID: 25556206
[TBL] [Abstract][Full Text] [Related]
28. AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival.
Salian-Mehta S; Xu M; Wierman ME
Mol Cell Endocrinol; 2013 Jul; 374(1-2):92-100. PubMed ID: 23648337
[TBL] [Abstract][Full Text] [Related]
29. An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo.
Subramanian M; Hayes CD; Thome JJ; Thorp E; Matsushima GK; Herz J; Farber DL; Liu K; Lakshmana M; Tabas I
J Clin Invest; 2014 Mar; 124(3):1296-308. PubMed ID: 24509082
[TBL] [Abstract][Full Text] [Related]
30. miR-34a Promotes Vascular Smooth Muscle Cell Calcification by Downregulating SIRT1 (Sirtuin 1) and Axl (AXL Receptor Tyrosine Kinase).
Badi I; Mancinelli L; Polizzotto A; Ferri D; Zeni F; Burba I; Milano G; Brambilla F; Saccu C; Bianchi ME; Pompilio G; Capogrossi MC; Raucci A
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2079-2090. PubMed ID: 30026277
[TBL] [Abstract][Full Text] [Related]
31. Engineering Axl specific CAR and SynNotch receptor for cancer therapy.
Cho JH; Okuma A; Al-Rubaye D; Intisar E; Junghans RP; Wong WW
Sci Rep; 2018 Mar; 8(1):3846. PubMed ID: 29497107
[TBL] [Abstract][Full Text] [Related]
32. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.
Linger RM; Cohen RA; Cummings CT; Sather S; Migdall-Wilson J; Middleton DH; Lu X; Barón AE; Franklin WA; Merrick DT; Jedlicka P; DeRyckere D; Heasley LE; Graham DK
Oncogene; 2013 Jul; 32(29):3420-31. PubMed ID: 22890323
[TBL] [Abstract][Full Text] [Related]
33. Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase.
Fridell YW; Jin Y; Quilliam LA; Burchert A; McCloskey P; Spizz G; Varnum B; Der C; Liu ET
Mol Cell Biol; 1996 Jan; 16(1):135-45. PubMed ID: 8524290
[TBL] [Abstract][Full Text] [Related]
34. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
[TBL] [Abstract][Full Text] [Related]
35. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma.
Yu H; Liu R; Ma B; Li X; Yen HY; Zhou Y; Krasnoperov V; Xia Z; Zhang X; Bove AM; Buscarini M; Parekh D; Gill IS; Liao Q; Tretiakova M; Quinn D; Zhao J; Gill PS
Br J Cancer; 2015 Aug; 113(4):616-25. PubMed ID: 26180925
[TBL] [Abstract][Full Text] [Related]
36. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
[TBL] [Abstract][Full Text] [Related]
37. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
Mackiewicz M; Huppi K; Pitt JJ; Dorsey TH; Ambs S; Caplen NJ
Breast Cancer Res Treat; 2011 Nov; 130(2):663-79. PubMed ID: 21814748
[TBL] [Abstract][Full Text] [Related]
38. Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells.
Pénzes K; Baumann C; Szabadkai I; Orfi L; Kéri G; Ullrich A; Torka R
Cancer Biol Ther; 2014; 15(11):1571-82. PubMed ID: 25482942
[TBL] [Abstract][Full Text] [Related]
39. Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members.
Papadakis ES; Cichoń MA; Vyas JJ; Patel N; Ghali L; Cerio R; Storey A; O'Toole EA
J Invest Dermatol; 2011 Feb; 131(2):509-17. PubMed ID: 21068757
[TBL] [Abstract][Full Text] [Related]
40. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.
Liu R; Gong M; Li X; Zhou Y; Gao W; Tulpule A; Chaudhary PM; Jung J; Gill PS
Blood; 2010 Jul; 116(2):297-305. PubMed ID: 20442363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]